Literature DB >> 12690981

Role of surgery in the treatment of microprolactinomas.

William T Couldwell1, Richard L Rovit, Martin H Weiss.   

Abstract

Prolactinomas are a common cause of reproductive and sexual dysfunction and account for a large proportion of pituitary adenomas. The objectives for treatment of hyperprolactinemia due to microprolactinomas are to suppress excessive hormone secretion, preserve residual pituitary function, and prevent disease recurrence. These objectives may be achieved in most patients harboring microprolactinomas by medical treatment with effective dopamine agonists or microsurgical or endoscopic adenomectomy by an experienced surgeon. The choice of pituitary surgery should be made in consideration of the volume and location of the adenoma, age of the patient, the desire for restoration of fertility, and the efficacy and tolerability of dopamine agonists. The presence of a symptomatic microprolactinoma, especially in a young patient, should remain an indication for micro- or endoscopic tumor removal. This article reviews the emergence of radiosurgery as a treatment for microprolactinomas.

Entities:  

Mesh:

Year:  2003        PMID: 12690981     DOI: 10.1016/s1042-3680(02)00090-6

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  4 in total

1.  Medical and surgical management of microprolactinoma.

Authors:  William T Couldwell; Martin H Weiss
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 2.  Treatment of pituitary tumors: surgery.

Authors:  Michael Buchfelder
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

3.  Cost-Effectiveness Analysis of Surgical versus Medical Treatment of Prolactinomas.

Authors:  Corinna C Zygourakis; Brandon S Imber; Rebecca Chen; Seunggu J Han; Lewis Blevins; Annette Molinaro; James G Kahn; Manish K Aghi
Journal:  J Neurol Surg B Skull Base       Date:  2016-09-27

4.  Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery.

Authors:  Yan-Long Han; Dong-Ming Chen; Cheng Zhang; Miao Pan; Xiao-Peng Yang; Yong-Gang Wu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.